Safety Alerts for Human Medical Products - Fluoroquinolone Antibacterial Drugs - Drug Safety Communication- Risk for possibly permanent nerve damage

Have you ever taken any Fluoroquinolone Antibacterial Drugs? Not sure? Read this and make sure...

Don

MedWatch The FDA Safety Information and Adverse Event Reporting Program

Fluoroquinolone Antibacterial Drugs: Drug Safety Communication- Risk for possibly permanent nerve damage

[Posted 08/15/2013]

AUDIENCE: Family Practice, Infectious Disease, Pharmacy

ISSUE: FDA has required the drug labels and Medication Guides for all fluoroquinolone antibacterial drugs be updated to better describe the serious side effect of peripheral neuropathy. This serious nerve damage potentially caused by fluoroquinolones may occur soon after these drugs are taken and may be permanent.

BACKGROUND: The risk of peripheral neuropathy occurs only with fluoroquinolones that are taken by mouth or by injection.  Approved fluoroquinolone drugs include levofloxacin (Levaquin), ciprofloxacin (Cipro), moxifloxacin (Avelox), norfloxacin (Noroxin), ofloxacin (Floxin), and gemifloxacin (Factive).  The topical formulations of fluoroquinolones, applied to the ears or eyes, are not known to be associated with this risk.

RECOMMENDATION: Make sure your patients know to contact you if they develop symptoms of peripheral neuropathy. Make sure your patients receive the Medication Guide with every prescription. If a patient develops symptoms of peripheral neuropathy, the fluoroquinolone should be stopped, and the patient should be switched to another, non-fluoroquinolone antibacterial drug, unless the benefit of continued treatment with a fluoroquinolone outweighs the risk. Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:

• Complete and submit the report Online: www.fda.gov/MedWatch/report.htm
• Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178

[08/15/2013 – Drug Safety Communication - FDA]

Page Last Updated: 08/15/2013
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.

Go there...
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm365302.htm

• Vaccines, Blood & Biologics
• Animal & Veterinary
• Cosmetics
• Tobacco Products

 

Safety

• Home
• Safety
• MedWatch The FDA Safety Information and Adverse Event Reporting Program
• Safety Information

• Safety Information

• Safety Alerts for Human Medical Products

• 2013 Safety Alerts for Human Medical Products
• 2012 Safety Alerts for Human Medical Products
• 2011 Safety Alerts for Human Medical Products
• 2010 Safety Alerts for Human Medical Products
• 2009 Safety Alerts for Human Medical Products
• 2008 Safety Alerts for Human Medical Products
• 2007 Safety Alerts for Human Medical Products
• 2006 Safety Alerts for Human Medical Products
• 2005 Safety Alerts for Human Medical Products
• 2004 Safety Alerts for Human Medical Products
• 2003 Safety Alerts for Human Medical Products
• 2002 Safety Alerts for Human Medical Products
• 2001 Safety Alerts for Human Medical Products
• 2000 Safety Alerts for Human Medical Products